{
    "clinical_study": {
        "@rank": "104412", 
        "brief_summary": {
            "textblock": "To evaluate tolerance, toxicity, and preliminary evidence of antitumor efficacy of\n      intralesionally administered tumor necrosis factor (TNF) and to define a maximum tolerated\n      dose (MTD) for single intralesional injections. In addition, to assess the effects of TNF\n      injections on Kaposi's sarcoma (KS) lesions as measured by P-32 magnetic resonance\n      spectroscopy."
        }, 
        "brief_title": "A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma", 
        "condition": [
            "Sarcoma, Kaposi", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Necrosis", 
                "Sarcoma, Kaposi", 
                "Skin Neoplasms", 
                "Sarcoma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  Biopsy-proven Kaposi's sarcoma (KS) with multiple cutaneous lesions.\n\n          -  Minimum life expectancy of 3 months.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following conditions or symptoms are excluded:\n\n          -  Clinically significant cardiac disease.\n\n          -  Known hemorrhagic diathesis or active bleeding disorder.\n\n          -  Clinically apparent vascular disease.\n\n          -  Known lipoprotein disorders.\n\n          -  History of seizure disorder or central nervous system (CNS) metastasis.\n\n          -  Additional malignancy.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Cardiac agents.\n\n          -  Anticoagulants.\n\n          -  Thrombolytic agents.\n\n          -  Nonsteroidal anti-inflammatory drugs.\n\n          -  Corticosteroids.\n\n          -  Aspirin.\n\n          -  Vasodilators.\n\n        Patients with the following are excluded:\n\n          -  Additional malignancies or other conditions listed in Patient Exclusion Co-Existing\n             Conditions.\n\n        Prior Treatment:\n\n        Excluded within 4 weeks of study entry:\n\n          -  Chemotherapy.\n\n          -  Radiotherapy.\n\n          -  Immunotherapy."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002262", 
            "org_study_id": "066A", 
            "secondary_id": "86-989"
        }, 
        "intervention": {
            "intervention_name": "Tumor Necrosis Factor", 
            "intervention_type": "Drug"
        }, 
        "keyword": [
            "Skin Neoplasms", 
            "Tumor Necrosis Factor", 
            "Acquired Immunodeficiency Syndrome"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "San Francisco", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "941102859"
                }, 
                "name": "San Francisco AIDS Clinic / San Francisco Gen Hosp"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002262"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of California, San Francisco", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 1988"
    }, 
    "geocoordinates": {
        "San Francisco AIDS Clinic / San Francisco Gen Hosp": "37.775 -122.419"
    }
}